Welcome to your daily round-up of everything happening in the world of neurorehab.
Research
New findings on the prevention of heart attacks and strokes
Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heart attacks and strokes, which are the most common causes of death worldwide. An international research team led by the Medical University of Vienna and the University Hospital of Würzburg has now made important progress in understanding this disease and identified potential new approaches for early detection and therapy. The results of the study were recently published in the journal Nature Cardiovascular Research.
Blast-related concussions linked to higher Alzheimer’s risk
US veterans of the wars in Afghanistan and Iraq who suffered mild traumatic brain injury from exposure to explosive blasts were found to have changes in cerebrospinal fluid proteins that are typically seen in people who develop Alzheimer’s disease, according to researchers at the University of Washington School of Medicine and VA Puget Sound Health Care System.The study was published in the journal Neurology.
African American veterans with PTSD have higher risk of re-hospitalisation after stroke
After a stroke, African American veterans previously diagnosed with PTSD were significantly more likely to be re-hospitalized than those without PTSD. PTSD did not raise the risk of post-stroke readmission in white veterans, according to research published in Stroke.
Technology
AI language model provides new insights into the development of brain diseases
A new AI language model can identify clinical symptoms in medical summaries and link them to brain tissue from donors of the Netherlands Brain Bank, yielding new insights into the development of individual disease progression and contributing to a better understanding of common misdiagnosis of brain diseases. Researchers say the model may, in the future, assist in making more accurate diagnoses.
Company updates
myTomorrows teams up with ALS Association
Global health tech company, myTomorrows has announced a new partnership with the ALS Association. Through the partnership, the ALS Association will tap into myTomorrows’ database of ongoing clinical trials and leverage its patient navigation service to ensure that treating physicians and those living with ALS are equipped with up-to-date information about appropriate pre-approval treatment options and ultimately guided towards relevant clinical trials.
Blackford and Pixyl partner to aid detection of neurological diseases
Blackford, a strategic AI platform and solutions provider, and Pixyl, an award-winning French MedTech firm specializing in AI-powered MRI solutions, announced a commercial partnership to bring Pixyl.Neuro™, a next-generation AI software for brain MRI analysis, to healthcare professionals via the Blackford Platform.
DiagnaMed strengthens intellectual property support
DiagnaMed has strengthened support for its intellectual property portfolio by becoming a client of Intellectual Property Ontario Partner Program and the National Research Council of Canada Industrial Research Assistance Program IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The company is said to have made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercialising CERVAI™ Brain Health AI solution.
